Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2800558 Title: FORMULATION PHARMACEUTIQUE STABLE DESTINÉE À UNE ADMINISTRATION PAR VOIE ORALE COMPRENANT DE LA LÉVOCÉTIRIZINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI, ET DU MONTÉLUKAST OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
137337895
WO application number:
KR2013000057
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2800558
WO publication number:
WO2013103262
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
04/01/2013
Grant date:
11/04/2018
EP publication date:
12/11/2014
WO publication date:
11/07/2013
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
11/04/2018
EP B1 publication date:
11/04/2018
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/01/2019
Expiration date (if granted and all annual fees paid):
04/01/2033

Applicant

Name:
Hanmi Pharm. Co., Ltd.
Legal Form:
From:
11/04/2018
Address:
214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-958, Korea (Republic) (KR)
To:

Inventor

1

Name:
KWON, Taek Kwan
Legal Form:
Address:
Suwon-si Gyeonggi-do 440-825, Korea (Republic) (KR)

2

Name:
KIM, Dong Ho
Legal Form:
Address:
Seoul 151-926, Korea (Republic) (KR)

3

Name:
KIM, Kyeong Soo
Legal Form:
Address:
Suwon-si Gyeonggi-do 440-710, Korea (Republic) (KR)

4

Name:
KIM, Yong Il
Legal Form:
Address:
Suwon-si Gyeonggi-do 442-872, Korea (Republic) (KR)

5

Name:
PARK, Jae Hyun
Legal Form:
Address:
Suwon-si Gyeonggi-do 443-737, Korea (Republic) (KR)

6

Name:
WOO, Jong Soo
Legal Form:
Address:
Suwon-si Gyeonggi-do 440-710, Korea (Republic) (KR)

Priority

Priority patent number:
20120001954
Priority date:
06/01/2012
Priority country:
Korea (Republic) (KR)

Classification

IPC or IDT classification:
A61K 9/48; A61K 31/496; A61K 31/495; A61K 31/4704; A61K 47/12; A61K 9/14; A61K 9/20; A61K 31/4965; A61K 9/28;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2018/08
Publication date:
03/05/2018
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2019/27
Publication date:
17/10/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
201815
Publication date:
11/04/2018
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type